A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Umirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms EuroCTO
- 29 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Mar 2017.
- 07 Apr 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Jan 2013 New trial record